Unilabs’ Acquisition of Blufstein


Philippi Prietocarrizosa Ferrero DU & Uría and Rebaza, Alcázar & De Las Casas advised on the deal

Unilabs announced today an agreement to acquire Blufstein, one of the top 3 accredited and private laboratories in Peru, for an undisclosed amount.

With a network of 31 collection centres and 4 hospital labs, Blufstein has acquired a strong reputation in the health market over the last decades and has become an ideal partner for organic growth.

The finalisation of the deal is subject to approval by the relevant regulatory authorities.


With over 199 laboratories and 44 imaging units and a broad catalogue of more than 2,500 diagnostic tests, Unilabs is one of Europe’s leading providers of clinical laboratory testing and medical diagnostic imaging services. Headquartered in Geneva, Switzerland the Unilabs Group serves private and public healthcare providers, local governments, pharmaceutical companies and the general public. The company employs more than 6,900 people worldwide, successfully operates laboratory and medical diagnostic imaging facilities in 14 countries, and generates annual revenues of €800m in 2016. Its network of facilities provides its customers with one of the broadest geographic footprints of any clinical laboratory and medical diagnostic services provider in Europe.


Founded by Jacobo Blufstein in 1955, Blufstein is one of the largest independent and accredited labs in Peru. It is based in Lima, where it runs one core lab, 31 collection centres, and four hospital labs. Blufstein has been constantly investing in sustaining its quality standards and establishing a customer centric service culture under the leadership of Jacobo and Nathan Blufstein. The company holds the ISO 9001:2008 certification; it is accredited for Biosecurity Level III, by the Center of Disease Control to test for lead, cadmium and mercury and by the College of American Pathologists.

Philippi Prietocarrizosa Ferrero DU & Uría advised Unilabs S.A. with Javier Ezeta (Picture), Omaira Zambrano and José Antonio De Izcue.

Rebaza, Alcázar & De Las Casas advised Grupo Blufstein with Felipe Boisset and Sebastián de la Puente.

Involved fees earner: Javier Ezeta – Philippi Prietocarrizosa Ferrero DU & Uría; Omaira Zambrano Nalvarte – Philippi Prietocarrizosa Ferrero DU & Uría; Jose Antonio de Izcue Tillit – Philippi Prietocarrizosa Ferrero DU & Uría; Felipe Boisset – Rebaza Alcazar & De Las Casas Abogados Financieros; Sebastian De La Puente – Rebaza Alcazar & De Las Casas Abogados Financieros;

Law Firms: Philippi Prietocarrizosa Ferrero DU & Uría; Rebaza Alcazar & De Las Casas Abogados Financieros;

Clients: Unilabs SA; Blufstein Laboratorio Clínico S.A. ;

Avatar

Author: Ambrogio Visconti.